Meeting
2017 Gastrointestinal Cancers Symposium
Neoadjuvant chemoradiotherapy (NCRT) compared with chemotherapy (NCT) in locally advanced squamous-cell cancer of the esophagus.
Authors
Xue Li
Henan Cancer Hospital, Zhengzhou University Affiliated Cancer Hospital, Zhengzhou, China
Xue Li , Daxuan Hao , Yuanyuan Yang , Xinyu Cheng , Yougai Zhang , Xiaoyuan Wu , Chunyu He , Jinsong Liu , Jianhua Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 202)
DOI
10.1200/JCO.2017.35.4_suppl.202
Abstract #
202
Poster Bd #
N6
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
A phase II study of early FDG-PET evaluation after one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy: Final report.
First Author: Ta-Chen Huang
Poster
2016 Gastrointestinal Cancers Symposium
Efficacy and feasibility of neoadjuvant chemotherapy and chemoradiotherapy for elderly patients with stage IB/II/III (excluding T4) esophageal cancer: Retrospective study.
First Author: Takahiro Miyamoto
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Pathologic complete response among patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A meta-analysis.
First Author: Charles Gaber
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A randomized controlled phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced esophageal cancer with no pathological complete response: JCOG2206 (SUNRISE Trial).
First Author: Satoru Matsuda